Evotec Se Stock Shares Outstanding
| EVOTF Stock | USD 13.83 0.00 0.00% |
Evotec SE fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Pink Sheet. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE pink sheet.
Evotec |
Evotec SE Company Shares Outstanding Analysis
Evotec SE's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Evotec SE Shares Outstanding | 176.95 M |
Most of Evotec SE's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Evotec SE has 176.95 M of shares currently outstending. This indicator is about the same for the Healthcare average (which is currently at 180.53 M) sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 69.05% higher than that of the company.
Evotec Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in shares outstanding category among related companies.
Evotec Fundamentals
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 176.95 M | |||
| Shares Owned By Insiders | 9.86 % | |||
| Shares Owned By Institutions | 66.12 % | |||
| Price To Earning | 347.66 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 618.03 M | |||
| Gross Profit | 151.54 M | |||
| EBITDA | 316.63 M | |||
| Net Income | 215.51 M | |||
| Cash And Equivalents | 887.88 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 326.34 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 3.57 X | |||
| Book Value Per Share | 6.95 X | |||
| Cash Flow From Operations | 122.24 M | |||
| Earnings Per Share | 0.04 X | |||
| Number Of Employees | 4.71 K | |||
| Beta | 1.01 | |||
| Market Capitalization | 4.14 B | |||
| Total Asset | 2.24 B | |||
| Retained Earnings | (618.9 M) | |||
| Working Capital | 42.51 M | |||
| Current Asset | 68.96 M | |||
| Current Liabilities | 26.45 M | |||
| Z Score | 7.2 | |||
| Net Asset | 2.24 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Evotec Pink Sheet
| 0.62 | TKPHF | Takeda Pharmaceutical | PairCorr |
Moving against Evotec Pink Sheet
| 0.93 | META | Meta Platforms Earnings Call Tomorrow | PairCorr |
| 0.9 | NVDA | NVIDIA Financial Report 22nd of May 2024 | PairCorr |
| 0.89 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
| 0.86 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.66 | MSFT | Microsoft Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Evotec Pink Sheet analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |